- Home
- AVIR vs CRMT Comparison
AVIR vs CRMT Comparison
Compare AVIR & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVIR | CRMT |
|---|---|---|
| Founded | 2012 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.4M | 266.5M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVIR | CRMT |
|---|---|---|
| Price | $3.61 | $27.78 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $6.00 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 397.2K | 181.4K |
| Earning Date | 11-12-2025 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,381,482,000.00 |
| Revenue This Year | N/A | $2.84 |
| Revenue Next Year | N/A | $5.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.01 |
| 52 Week Low | $2.46 | $17.78 |
| 52 Week High | $4.02 | $62.72 |
Technical Indicators
Market Signals| Indicator | AVIR | CRMT |
|---|---|---|
| Relative Strength Index (RSI) | 64.59 | 60.56 |
| Support Level | $3.34 | $24.11 |
| Resistance Level | $3.63 | $26.61 |
| Average True Range (ATR) | 0.15 | 1.65 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 86.18 | 81.74 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About CRMT America's Car-Mart Inc
America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.